Scientists hunt for brain cancer clues in tiny molecules
NCT ID NCT01849952
Summary
This study aimed to understand if measuring levels of a tiny molecule called microRNA-10b in brain tumor samples could help doctors predict patient survival and better classify different types of brain cancer. Researchers collected tumor, blood, and spinal fluid samples from 94 adults with gliomas (a type of brain tumor) who were having surgery. They analyzed these samples to see if higher levels of this molecule were linked to more aggressive tumors or shorter survival times.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, 03756, United States
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
-
Tufts Medical Center
Boston, Massachusetts, 02111, United States
-
University of Vermont
Burlington, Vermont, 05405, United States
Conditions
Explore the condition pages connected to this study.